当前位置: 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > MCE信号通路 > 代谢酶/蛋白酶 > BAY-2402234
BAY-2402234
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:8年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:91228
参观次数:11479122
联系我们
MedChemExpress
电话:021-58955995
联系人:客服部 (请说明是在易推广看到的!谢谢)
手机:13611715263
邮编:201203
邮箱:sales@medchemexpress.cn
地址:上海上海
详细内容
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
BAY-2402234
CAS No. : 2225819-06-5
MCE 站:BAY-2402234
产品活性:BAY-2402234 是一个选择性的、二氢乳清酸脱氢酶 (DHODH) 的抑制剂,可用于骨髓恶性肿瘤 (myeloid malignancies)的相关研究。
研究领域:Metabolic Enzyme/Protease | Cell Cycle/DNA Damage
作用靶点:Dihydroorotate Dehydrogenase | DNA/RNA Synthesis
In Vitro: BAY-2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity. In vitro, it potently inhibits proliferation of AML cell lines in the sub-nanomolar to low-nanomolar range. BAY-2402234 induces differentiation of AML cell lines also in a sub-nanomolar to low-nanomolar range, demonstrating the anticipated mode of action in cellular mechanistic assays.
In Vivo: BAY-2402234 exhibits strong in vivo anti-tumor efficacy in monotherapy in several subcutaneous and disseminated AML xenografts as well as AML patient-derived xenograft (PDX) models. Target engagement of the novel DHODH inhibitor BAY-2402234 can be observed by increase of tumoral and plasma dihydroorotate levels after treatment with the inhibitor. Consistent with the in vitro data BAY-2402234 induces AML differentiation in vivo as detected by upregulation of differentiation cell surface markers in xenograft and PDX models after treatment with the inhibitor. Furthermore, differentiation-associated transcriptomic changes are evident following a single administration of BAY-2402234 in vivo.
相关产品:Clinical Compound Library Plus | Bioactive Compound Library Plus | IBU-DC Phosphoramidite | 2,4-D sodium salt | N6-Benzoyl-2'-deoxy-5'-O-DMT-a-adenosine 3'-CE phosphoramidite | Thailanstatin D | Carboplatin-d4 | Caracemide | N-DMTr-Morpholino-U-5'-O-phosphoramidite | Farudodstat | Ara-ATP | DNA31 | 2'-OMe-Ac-C Phosphoramidite | hDHODH-IN-12 | Dasabuvir | DNA Gyrase-IN-4 | Uridine triphosphate-13C9,15N2 sodium | 5-Methylcytosine | Cidofovir dihydrate | Capecitabine-d11 | DHODH-IN-21 | 5-Fluoro-2′-deoxy-UTP | DMT-2'-F-dA(bz) phosphoramidite | Tezacitabine | Mequindox | TH287 hydrochloride | DNA Gyrase-IN-1 | DMT-2'-F-Cytidine Phosphoramidite | 2'-O-MOE-5-Me-rU | Levofloxacin sodium | GC7 Sulfate
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿*全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
热门标签:bay-2402234